Search Results - "Sirac Dilber, M"

Refine Results
  1. 1

    Good manufacturing practice and clinical-grade human embryonic stem cell lines by Unger, Christian, Skottman, Heli, Blomberg, Pontus, Sirac Dilber, M., Hovatta, Outi

    Published in Human molecular genetics (15-04-2008)
    “…Human embryonic stem cell (hESC) lines, after directed differentiation, hold the greatest potential for cell transplantation treatment in many severe diseases…”
    Get full text
    Journal Article
  2. 2

    Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components by Alici, Evren, Sutlu, Tolga, Björkstrand, Bo, Gilljam, Mari, Stellan, Birgitta, Nahi, Hareth, Quezada, Hernan Concha, Gahrton, Gösta, Ljunggren, Hans-Gustaf, Dilber, M. Sirac

    Published in Blood (15-03-2008)
    “…Multiple myeloma (MM) is an incurable plasma cell malignancy with poor outcome. The most promising therapeutic options currently available are combinations of…”
    Get full text
    Journal Article
  3. 3

    The derivation of clinical-grade human embryonic stem cell lines by Skottman, Heli, Dilber, M. Sirac, Hovatta, Outi

    Published in FEBS letters (22-05-2006)
    “…The pluripotent nature of human embryonic stem cells (hESC) has attracted great interest in using them as a source of cells or tissue in cell therapy. However,…”
    Get full text
    Journal Article
  4. 4

    NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy by Malmberg, Karl-Johan, Bryceson, Yenan T., Carlsten, Mattias, Andersson, Sandra, Björklund, Andreas, Björkström, Niklas K., Baumann, Bettina C., Fauriat, Cyril, Alici, Evren, Dilber, M. Sirac, Ljunggren, Hans-Gustaf

    Published in CANCER IMMUNOLOGY IMMUNOTHERAPY (01-10-2008)
    “…Insights into the molecular basis for natural killer (NK) cell recognition of human cancer have been obtained in recent years. Here, we review current…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy by Preuss, Ellen, Treschow, Alexandra, Newrzela, Sebastian, Brücher, Daniela, Weber, Kristoffer, Felldin, Ulrika, Alici, Evren, Gahrton, Gösta, von Laer, Dorothee, Dilber, M Sirac, Fehse, Boris

    Published in Human gene therapy (01-08-2010)
    “…Conditional elimination of infused gene-modified alloreactive T cells, using suicide gene activation, has been shown to be an efficient strategy to abrogate…”
    Get more information
    Journal Article
  6. 6

    Retroviral gene transfer into primary human natural killer cells by Alici, Evren, Sutlu, Tolga, Sirac Dilber, M

    “…Modulation of intracellular signaling pathways or receptor expression in natural killer (NK) cells by genetic manipulation is an attractive possibility in…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9

    Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model by Alici, Evren, Konstantinidis, Kyriakos V, Sutlu, Tolga, Aints, Alar, Gahrton, Gösta, Ljunggren, Hans-Gustaf, Dilber, M. Sirac

    Published in Experimental hematology (01-12-2007)
    “…Objective Despite advances in autologous stem cell transplantation and chemotherapy, multiple myeloma (MM) remains an incurable disease. Due to the role of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: A dose-dependent effect of osterix over-expression by Kärner, Elerin, Unger, Christian, Cerny, Radim, Ährlund-Richter, Lars, Ganss, Bernhard, Dilber, M. Sirac, Wendel, Mikael

    Published in Journal of cellular physiology (01-02-2009)
    “…Enhanced differentiation of human embryonic stem cells (HESCs), induced by genetic modification could potentially generate a vast number of diverse cell types…”
    Get full text
    Journal Article
  12. 12

    Efficient gene transfer into primary human natural killer cells by retroviral transduction by Guven, Hayrettin, Konstantinidis, Kyriakos V., Alici, Evren, Aints, Alar, Abedi-Valugerdi, Manuchehr, Christensson, Birger, Ljunggren, Hans-Gustaf, Dilber, M. Sirac

    Published in Experimental hematology (01-11-2005)
    “…To optimize retroviral gene transfer into primary human natural killer (NK) cells. NK cells from healthy donors were expanded ex vivo for a period of 21 days…”
    Get full text
    Journal Article
  13. 13

    Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene by Asklund, Thomas, Appelskog, Ioulia B, Ammerpohl, Ole, Langmoen, Iver A, Dilber, M Sirac, Aints, Alar, Ekström, Tomas J, Almqvist, Per M

    Published in Experimental cell research (01-04-2003)
    “…The ability of herpes simplex virus type 1 thymidine kinase (HSV-tk)-expressing cells incubated with ganciclovir (GCV) to induce cytotoxicity in neighboring…”
    Get full text
    Journal Article
  14. 14

    Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells by Konstantinidis, Kyriakos V., Alici, Evren, Aints, Alar, Christensson, Birger, Ljunggren, Hans-Gustaf, Dilber, M. Sirac

    Published in Experimental hematology (01-02-2005)
    “…Anti-tumor effects mediated by adoptively transferred natural killer (NK) cells are dependent on the presence of interleukin-2 (IL-2). IL-2 is considered to be…”
    Get full text
    Journal Article
  15. 15

    Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo by DILBER, M. S, ABEDI, M. R, CHRISTENSSON, B, BJÖRKSTRAND, B, KIDDER, G. M, NAUS, C. C. G, GAHRTON, G, SMITH, C. I. E

    Published in Cancer research (Chicago, Ill.) (15-04-1997)
    “…Transfer of the herpes simplex thymidine kinase gene (HSVtk) into tumor cells followed by the administration of ganciclovir (GCV) provides a potential strategy…”
    Get full text
    Journal Article
  16. 16

    Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma by Alici, Evren, Konstantinidis, Kyriakos V., Aints, Alar, Dilber, M. Sirac, Abedi-Valugerdi, Manuchehr

    Published in Experimental hematology (01-11-2004)
    “…Lack of good models for in vivo detection of multiple myeloma (MM) cells hampers our understanding of the disease. Our objective was to establish a murine…”
    Get full text
    Journal Article
  17. 17

    Derivation of human skin fibroblast lines for feeder cells of human embryonic stem cells by Unger, Christian, Felldin, Ulrika, Nordenskjöld, Agneta, Dilber, M Sirac, Hovatta, Outi

    Published in Current protocols in stem cell biology (01-06-2008)
    “…After the first derivations of human embryonic stem cell (hESC) lines on fetal mouse feeder cell layers, the idea of using human cells instead of mouse cells…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Intercellular spread of GFP-VP22 by Aints, Alar, Dilber, M. Sirac, Smith, C. I. Edvard

    Published in The journal of gene medicine (01-07-1999)
    “…Background The herpes simplex virus type 1 (HSV‐1) VP22 polypeptide has been reported to mediate intercellular trafficking of heterologous proteins fused to…”
    Get full text
    Journal Article
  20. 20

    Enhanced ouabain resistance gene as a eukaryotic selection marker by Aints, Alar, Belusa, Roger, Andersson, Ronnie M, Güven, Hayrettin, Dilber, M Sirac

    Published in Human gene therapy (20-05-2002)
    “…Current selection markers allow selection by antibiotics or fluorescent/magnetic sorting by green fluorescent protein or membrane antigens. Antibiotic…”
    Get more information
    Journal Article